Innoviva, Inc. ( INVA) - Stock Earnings
INVA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 89.9 million USD | 107.8 million USD |
| 2025Q4 | 164.2 million USD | 118.0 million USD |
| 2026Q1 | 186.6 million USD | 98.0 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
INVA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 179.7 million USD | 310.5 million USD |
| 2024 | 23.4 million USD | 358.7 million USD |
| 2025 | 271.2 million USD | 425.1 million USD |
| 2026 Est. | — | — |
INVA
Price: $22.42
52 week price:
Payout Ratio Range:
Earnings Per Share: 6.26 USD
P/E Ratio: 3.60
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 549332
Ebitda: 66.9 millionMarket Capitalization: 1.6 billion